These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 16026694

  • 1. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Kellie SJ, Chaku J, Lockwood LR, O'Regan P, Waters KD, Wong CK, Australian and New Zealand Children's Haematology Oncology Group.
    Eur J Cancer; 2005 Jul; 41(11):1588-96. PubMed ID: 16026694
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
    Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA.
    Cancer; 2008 Feb 01; 112(3):581-8. PubMed ID: 18072268
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy.
    Lopez-Aguilar E, Sepulveda-Vildosola AC, Rivera-Marquez H, Cerecedo-Diaz F, Santacruz-Castillo E, Valdez-Sanchez M, Arias-Gomez J, Quintana-Roldan G.
    Arch Med Res; 1998 Feb 01; 29(4):313-7. PubMed ID: 9887549
    [Abstract] [Full Text] [Related]

  • 13. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
    Verlooy J, Mosseri V, Bracard S, Tubiana AL, Kalifa C, Pichon F, Frappaz D, Chastagner P, Pagnier A, Bertozzi AI, Gentet JC, Sariban E, Rialland X, Edan C, Bours D, Zerah M, Le Gales C, Alapetite C, Doz F.
    Eur J Cancer; 2006 Nov 01; 42(17):3004-14. PubMed ID: 16956759
    [Abstract] [Full Text] [Related]

  • 14. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.
    J Clin Oncol; 2006 Aug 20; 24(24):3858-64. PubMed ID: 16921038
    [Abstract] [Full Text] [Related]

  • 15. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.
    J Clin Oncol; 2004 Dec 15; 22(24):4881-7. PubMed ID: 15611503
    [Abstract] [Full Text] [Related]

  • 16. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
    Osumi AK, Mclendon RE, Tien RD, Friedman HS, Graham M, Hockenberger B, Halperin EC, Oakes WJ.
    Clin Neuropathol; 1994 Dec 15; 13(5):281-5. PubMed ID: 7805312
    [Abstract] [Full Text] [Related]

  • 17. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K, Urbach H, Helmstaedter C, Pels H, Glasmacher A, Kraus JA, Klockgether T, Schmidt-Wolf I, Schlegel U.
    Arch Neurol; 2003 Apr 15; 60(4):563-8. PubMed ID: 12707070
    [Abstract] [Full Text] [Related]

  • 18. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R.
    J Clin Oncol; 2006 Sep 01; 24(25):4202-8. PubMed ID: 16943538
    [Abstract] [Full Text] [Related]

  • 19. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Kiewe P, Fischer L, Martus P, Thiel E, Korfel A.
    Cancer; 2008 Apr 15; 112(8):1812-20. PubMed ID: 18318432
    [Abstract] [Full Text] [Related]

  • 20. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS.
    Eur J Cancer; 2005 Mar 15; 41(5):727-34. PubMed ID: 15763649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.